Personalized follow-up care after breast cancer treatment
Part of Cancer, Skin clinical trials.
This trial tests whether a personalized follow-up plan after breast cancer surgery (instead of a fixed schedule) can improve care and support after treatment. It may help people know what follow-up is best for them as they move into survivorship.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman age 40 or older.
- You have completed curative treatment for invasive breast cancer that has not spread to other parts of the body.
- You are currently deciding how you will do follow-up checkups and aftercare after treatment.
- You can understand Dutch well enough to read and talk with the study team.
- You should not be in a different study that requires a fixed follow-up schedule with set visits and/or scans.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a patient-led follow-up approach after early breast cancer treatment, where you may have more control and flexibility instead of routine hospital visits, while still on hormone therapy.
This trial will create a personalized exercise plan for breast cancer patients after surgery, using a computer program that understands your medical history. The goal is to help you recover better and improve your quality of life.
This study looks at a more personalized way to follow up after breast-conserving surgery (lumpectomy). It may use extra imaging scans to detect any return of cancer early, which could help you feel more secure and get treatment sooner if needed.
This trial compares standard follow-up visits versus more intensive follow-up for people with early breast cancer after their main treatment. The goal is to see whether closer monitoring finds problems earlier or improves outcomes.
This follow-up study is for people who took part in earlier breast cancer gene tests (TAILORx or RxPONDER). It collects health information and tumor tissue over time to learn more about how breast cancer behaves after treatment.
This study tests whether patients who have finished breast cancer treatment and are doing well can safely have fewer doctor visits and scans. Researchers want to see if reducing routine surveillance affects quality of life and health outcomes.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.